Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)

Q: When is the deadline for Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)?

This is a forecast opportunity; the agency has not posted dates yet.

Q: Who is eligible for Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)?

Eligible applicants: Private colleges & universities; Tribal organizations; Tribal governments; Public & Indian housing authorities; Nonprofits (501(c)(3)); School districts; For-profit businesses; Small businesses.

National Institutes of Health

Federal Grants for Science Research Healthcare Grants

Funding Amount

$6,600,000 total

Deadline

Forecast — dates not yet posted

Grant Type

Federal

Can we apply?

Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.

Eligible organizations

Private colleges & universities
Tribal organizations
Tribal governments
Public & Indian housing authorities
Nonprofits (501(c)(3))
School districts
For-profit businesses
Small businesses

Overview

The NIH Common Fund, with other NIH Institutes and Centers (ICs), intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for the Gabriella Miller Kids First Pediatric Research Program (Kids First) , which seeks to help researchers uncover new insights into the biology of childhood cancer and congenital anomalies, including the discovery of shared genetic pathways between these disorders, to understand the underlying mechanisms of disease and ultimately lead to more targeted therapies and interventions for patients and families. The program’s Genome Sequencing Center initiative will fund adding data to the resource, expanding data types as technologies mature and scientific rationale warrant, and expanding to add clinic-based data sources. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will utilize the U24 activity code. Investigators with expertise and insights into childhood cancer and/or congenital abnormalities data are encouraged to begin to consider applying for this new NOFO.